Research & Development Disclosures

Last updated: July 27, 2026

TorrideX is an early-stage R&D program. The principal conversion mechanism has not yet been validated through repeatable, auxiliary-adjusted laboratory power measurements.

1. Evidence status

2. Technical risks

Material risks include insufficient thermionic emission, space-charge limitation, plasma instability, recombination, collision losses, excessive auxiliary power, current leakage, thermal losses, contamination, electrode degradation, gap control and sealing.

3. Measurement risks

High-voltage, plasma and thermal experiments can produce false signals through capacitive current, displacement current, leakage, thermoelectric voltages, common-mode error, electromagnetic interference, parasitic charging and transient behavior. Controlled baselines and uncertainty analysis are required.

4. Development and schedule risks

Hardware development may require redesign, additional capital, specialist support and longer schedules than anticipated. A successful laboratory result may not translate directly into a manufacturable or economically viable product.

5. Persistent-source and regulatory risks

The first validation stage is non-radioactive. Future configurations involving regulated radioactive materials would require qualified source partners, containment and shielding engineering, safety analysis, secure supply, environmental and transport review, and applicable government licenses and approvals. Such configurations may prove impractical or may not be approved.

6. Market and financing risks

Even if the technology is validated, market adoption is not assured. Alternatives may improve, qualification cycles may be long, customer economics may be unfavorable and substantial additional financing may be required.

7. No investment or technical advice

This page is informational and is not investment, legal, regulatory, safety or engineering advice.